Medtech Execs On The Move, February 2016
Executive Summary
Recent executive-level company changes and promotions in the medical device and diagnostics industries.
You may also be interested in...
EU Investment Looks To Regenerate Tissue, As Well As Its Economy
Xeltis, a Netherlands-based company producing cardiovascular implants to stimulate natural regeneration of biological tissue, has received funding from the European Union’s rescue fund.
FDA Preps Device Makers To Use eSTAR For De Novo Requests
Manufacturers can’t use the US FDA’s voluntary eSTAR product submission program for de novo requests until January – but they can start practicing now on how to use eSTAR for that review pathway.
Exec Chat: CMR Surgical Prepares For Intensifying Competition In RAS
In an interview with Medtech Insight, Per Vegard Nerserth, CEO of CMR Surgical, discusses how the company adapted to the pandemic, its future plans, and how the competition for market dominance is shaping up.